Psychopharmacological interventions in fragile X syndrome, fetal alcohol syndrome, Prader-Willi syndrome, Angelman syndrome, Smith Magenis syndrome, and velocardiofacial syndrome

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

An overview of psychopharmacological interventions in developmental disorders is presented, followed by a review of treatment in fragile X syndrome, fetal alcohol syndrome, Angelman syndrome, Prader-Willi syndrome, Smith-Magenis syndrome, and velocardiofacial syndrome. Each of these disorders has a specific behavioral phenotype, and we are making progress in clarifying each of their psychopharmacological phenotypes. Common problems such as attention deficit hyperactivity disorder and mood lability are reviewed, although unique aspects of each disorder are emphasized.

Original languageEnglish (US)
Pages (from-to)305-313
Number of pages9
JournalMental Retardation and Developmental Disabilities Research Reviews
Volume5
Issue number4
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Smith-Magenis Syndrome
Angelman Syndrome
DiGeorge Syndrome
Prader-Willi Syndrome
Fetal Alcohol Spectrum Disorders
Fragile X Syndrome
Phenotype
Attention Deficit Disorder with Hyperactivity

Keywords

  • ADHD
  • Angelman syndrome
  • Fetal alcohol syndrome
  • Fragile X syndrome
  • Mental retardation
  • Prader-Willi syndrome
  • Psychopharmacology
  • Smith-Magenis syndrome
  • Stimulants
  • Velocardiofacial syndrome
  • Williams syndrome

ASJC Scopus subject areas

  • Genetics(clinical)
  • Pediatrics, Perinatology, and Child Health
  • Neuropsychology and Physiological Psychology

Cite this

@article{0f4510e479264c5d8242d3099fef11d7,
title = "Psychopharmacological interventions in fragile X syndrome, fetal alcohol syndrome, Prader-Willi syndrome, Angelman syndrome, Smith Magenis syndrome, and velocardiofacial syndrome",
abstract = "An overview of psychopharmacological interventions in developmental disorders is presented, followed by a review of treatment in fragile X syndrome, fetal alcohol syndrome, Angelman syndrome, Prader-Willi syndrome, Smith-Magenis syndrome, and velocardiofacial syndrome. Each of these disorders has a specific behavioral phenotype, and we are making progress in clarifying each of their psychopharmacological phenotypes. Common problems such as attention deficit hyperactivity disorder and mood lability are reviewed, although unique aspects of each disorder are emphasized.",
keywords = "ADHD, Angelman syndrome, Fetal alcohol syndrome, Fragile X syndrome, Mental retardation, Prader-Willi syndrome, Psychopharmacology, Smith-Magenis syndrome, Stimulants, Velocardiofacial syndrome, Williams syndrome",
author = "Hagerman, {Randi J}",
year = "1999",
doi = "10.1002/(SICI)1098-2779(1999)5:4<305::AID-MRDD8>3.0.CO;2-L",
language = "English (US)",
volume = "5",
pages = "305--313",
journal = "Mental Retardation and Developmental Disabilities Research Reviews",
issn = "1080-4013",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Psychopharmacological interventions in fragile X syndrome, fetal alcohol syndrome, Prader-Willi syndrome, Angelman syndrome, Smith Magenis syndrome, and velocardiofacial syndrome

AU - Hagerman, Randi J

PY - 1999

Y1 - 1999

N2 - An overview of psychopharmacological interventions in developmental disorders is presented, followed by a review of treatment in fragile X syndrome, fetal alcohol syndrome, Angelman syndrome, Prader-Willi syndrome, Smith-Magenis syndrome, and velocardiofacial syndrome. Each of these disorders has a specific behavioral phenotype, and we are making progress in clarifying each of their psychopharmacological phenotypes. Common problems such as attention deficit hyperactivity disorder and mood lability are reviewed, although unique aspects of each disorder are emphasized.

AB - An overview of psychopharmacological interventions in developmental disorders is presented, followed by a review of treatment in fragile X syndrome, fetal alcohol syndrome, Angelman syndrome, Prader-Willi syndrome, Smith-Magenis syndrome, and velocardiofacial syndrome. Each of these disorders has a specific behavioral phenotype, and we are making progress in clarifying each of their psychopharmacological phenotypes. Common problems such as attention deficit hyperactivity disorder and mood lability are reviewed, although unique aspects of each disorder are emphasized.

KW - ADHD

KW - Angelman syndrome

KW - Fetal alcohol syndrome

KW - Fragile X syndrome

KW - Mental retardation

KW - Prader-Willi syndrome

KW - Psychopharmacology

KW - Smith-Magenis syndrome

KW - Stimulants

KW - Velocardiofacial syndrome

KW - Williams syndrome

UR - http://www.scopus.com/inward/record.url?scp=0033373434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033373434&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2779(1999)5:4<305::AID-MRDD8>3.0.CO;2-L

DO - 10.1002/(SICI)1098-2779(1999)5:4<305::AID-MRDD8>3.0.CO;2-L

M3 - Article

VL - 5

SP - 305

EP - 313

JO - Mental Retardation and Developmental Disabilities Research Reviews

JF - Mental Retardation and Developmental Disabilities Research Reviews

SN - 1080-4013

IS - 4

ER -